The effects of a combined exercise intervention on gut microbiomes and systemic inflammatory biomarkers in NAFLD patients

Mr Christiaan Hattingh0 个研究点目标入组 46 人开始时间: 2023年9月20日最近更新: 2023年9月26日

适应症

试验速览

暂无简介。

•(i)A diagnosis of NAFLD
•(ii)No other liver disease or cancer present
•(iii)Other well-managed comorbidities, e.g. Type 2 Diabetes Mellitus (T2DM), and hypertension, are approved for the study
•(iv)No recent or current exercise performed
•(v)Commit to the cross-sectional study and assess for the longitudinal study
•(vi)Complete consent form

•(i) Younger than 18 years of age
•(ii) Serious cardiovascular, respiratory, or neurological diseases and cancers
•(iii) Poorly controlled hypertension, glucose regulation or other serious chronic diseases
•(iv) A disability that could prevent the completion of exercises
•(v) High-risk participants with contraindications to exercise
•(vi) Currently exercising more than 60 minutes per week
•(vii) Participation in conflicting studies
•(viii) Participants with internal artefacts that may obscure DXA readings
•(ix) Participants who are pregnant, attempting to conceive or lactating.
•(x) Participants exposed to radiation levels deemed unsafe in the DXA pre-testing preparation checklist.
•(xi) Participants who cannot complete the 1RM and VO2max protocols.
•(xii) Medications that could alter outcome measures

发起方

Mr Christiaan Hattingh